No info available.

• Ph D in Bioengineering, Korea National University of Transportation (2014)
• MS in Bioengineering, Korea National University of Transportation (2010)
• B.Pharm. in Pharmaceutics, University of Development Alternative (2007)

• Deciphering the Role of Quaternary N in O2 Reduction over Controlled N-Doped Carbon Catalysts Chemistry of Materials 32 4 (2020), Enamul Haque, Ali Zavabeti, Nizam Uddin, Yichao Wang, Md Arifur Rahim, Nitu Syed, Kai Xu, Azmira Jannat, Farjana Haque, Bao Yue Zhang, Mahbubul Alam Shoaib, Sayed Shamsuddin, Md Nurunnabi, Andrew I Minett, Jian Zhen Ou, Andrew T Harris.
• Hyaluronic Acid‐Doxorubicin Nanoparticles for Targeted Treatment of Colorectal Cancer Bioengineering & Translational Medicine (2020), Daniel C. Pan, Vinu Krishnan, Alyssa K. Salinas, Jayoung Kim, Tao Sun, Sagi Ravid, Kevin Peng, Debra Wu, Md Nurunnabi, Jeffery A. Nelson , Zachary Niziolek , Junling Guo , Samir Mitragotri.
• Reply to Peiretti et al.: Effect of CAGE on fat uptake and food intake Proceedings of the National Academy of Sciences (2020), Md Nurunnabi, Kelly N. Ibsen, Eden E. Tanner, Samir Mitragotri.
• Green Chemistry Synthesis of Silver Nanoparticles and Their Potential Anticancer Effects Cancers (2020), ZA Ratan , MF Haidere, Md Nurunnabi, SM Shahriar, AJS Ahammad, YY Shim , MJT Reaney, JY Cho.
• Biocompatibility Assessment of Nanomaterials Using Zebra Fish as a Model (2019), Md Nurunnabi.

• Materials in Medicine: Targeting Therapy and Imaging (2020), Volume New Mexico, Md Nurunnabi.
• Bioengineering of materials for advancement in diagnosis and therapy (2020), Volume UTEP, El Paso, Md Nurunnabi.
• Bioengineered approached to control diabetes and obesity (2019), Volume Guyana, Md Nurunnabi.
• Oral delivery of a therapeutic gene encoding glucagon-like peptide 1 to treat high fat diet-induced diabetes (2019), Volume El Paso, Md Nurunnabi.
• From Materials to Medicine (2019), Volume El Paso, Md Nurunnabi.

No info available.